Study shows mastectomy plus reconstruction is riskiest, costliest treatment option
Mastectomy plus reconstruction for patients with early-stage breast cancer is significantly riskier and costlier than other less-invasive options, MD Anderson researchers have found. Their study, published Sept. 27 in the Journal of the National Cancer Institute, is the first to break down the complication rates and costs for breast cancer treatment options.Women with early-stage breast cancer have a number of treatment options, including...

Mastectomy plus reconstruction equals rise in complication rates, costs
The 140,000 U.S. women diagnosed each year with early-stage breast cancer, when the tumor is still small and hasn’t spread, have a variety...
Breast-conserving therapy on the rise, but off-limits to some
The first national review of breast-conserving therapy (BCT) shows that over the last 13 years, rates of this treatment for early-stage breast...